reports
Winmark Corp: 1 director
A director at Winmark Corp sold 3,021 shares at 425.488USD and the significance rating of the trade was 89/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabi...
The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabis Introduces New Premium Strain ‘Platinum Pavé’ TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, is thrilled to announce the latest small batch indica strain by premium craft cannabis brand, : Platinum Pavé. This exceptional new cultivar is one of the first from Broken Coast's state-of-the-art Vancouver Island, BC facility. Platinum Pavé is meticulously grown under optimized conditions in single-strain, laborator...
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameda...
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- (“Redhook”), Seattle’s pioneering craft brewery and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), officially presents their new partnership with the , supporting student-athletes at the University of Washington (UW). Together, they launched Montlake Gameday Gold Lager, the Official Beer of the Montlake Futures NIL Collective. This unique lager stands out as the only beer dedicate...
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season! TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, is excited to announce the launch of its 2024 Holiday Cannabis Gift Guide. The guide features a handpicked selection of cannabis products that are perfect for the festive season. With offerings from Tilray's ...
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of ...
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit Company to host conference call and webcast with key opinion leader on December 3, 2024, at 7:30 a.m. ET FREDERICK, Md., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that updated efficacy and safety data from the Phase 2b trial of Descartes-08 in patients...
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide Explore Award-Winning Craft Beers, Premium Spirits, Sparkling Water, Non-Alcoholic Brews, and New Hemp-Derived THC Drinks Discover the Best Craft Brews from Across the U.S. at Tilray's Festive Holiday Brewpub Events NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is pleased to present its 2024 holiday spirits and craft beverage gift guide, full of unique gift ideas for your loved ones. This curated selection featu...
Tilray Medical bringt erste in Deutschland angebaute kommerzielle medi...
Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und medizinischen Fachkräften stärkt, um fundierte, individuelle Gesundheitsentscheidungen zu treffen, hat heute die Markteinführung seiner ersten kommerziellen, in Deuts...
Tilray Medical lance ses premiers produits commerciaux à base de canna...
Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue NEUMÜNSTER, Allemagne, 14 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray Brands ») (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, a annoncé aujourd’hui le lancement de ses premières fleurs de cannabis thérapeutique ...
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer Amer...
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- , Long Island’s original craft brewery and a subsidiary of Tilray Brands (NASDAQ: TLRY and TSX: TLRY), proudly announces Blitz Beer, a refreshing new American Lager added to Blue Point’s winter seasonal lineup. Available November through February, Blitz Beer offers a crisp, sessionable profile perfect for colder months and festive gatherings. New York has a rich tradition of brewing exceptional American l...
Tilray Medical Launches its First Commercial “Grown in Germany” Medica...
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility...
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party Join 10 Barrel Brewing for a Free Community Event Celebrating the Snowboard Season with Live Music, Giveaways, and the Premiere of the "Beer Lodge" film at 10 Barrel’s Winter Party BEND, Ore., Nov. 13, 2024 (GLOBE NEWSWIRE) -- . (“10 Barrel Brewing” or “10 Barrel”), a pioneering craft brewery and subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to announce the , a free, all-ages event celebrating the festivities of the winter season, community, and of course, great beer. The event will take ...
Breckenridge Distillery's Latest Creation is the Perfect Addition to Y...
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka BRECKENRIDGE, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), releases its new for the holiday season. Whether enjoyed neat, on the rocks, or as the star ingredient of a favorite holiday cocktail, Breckenridge Distillery’s Candy Cane Vodka brings holiday cheer to those aged 21 and up and is now available in retailers nationwide. is 80 proof / 40% ABV...
Experience the Ultimate 420 Festival Celebration with SweetWater's 20t...
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025 ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- , (“SweetWater Brewing” or “SweetWater”), the hottest craft brewer in Atlanta and the largest in the Southeast, a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), has unveiled the headliners for the 2025 , marking the festival’s 20th anniversary with an epic celebration of music, cultur...
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics Announces New Employment Inducement Grants FREDERICK, Md., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting of inducement awards to two new employees. On November 4, 2024, the Company issued to these employees options to purchase an aggregate of 4,854 shares of the Company’s common stock with an exercise price of $19.11, the closing trading price of the Company’s common stock on the...
Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabi...
Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt SYDNEY, Australien, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und Ärzten stärkt, um informierte, individuelle Gesundheitsentscheidungen zu treffen, freut sich, die Endergebnisse einer neuen wissenschaftlichen Studie mit dem Titel „Oral Cannabis Ext...
Tilray Medical annonce les résultats positifs d’une étude sur l’extrai...
Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie SYDNEY, Australie, 07 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc., ci-après « Tilray Brands » (NASDAQ : TLRY et TSX : TLRY) et leader mondial du cannabis thérapeutique, qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, se réjouit d’annoncer les conclusions finales de la nouvelle étude scientifique conduite par son équipe i...
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engag...
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The ...
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results an...
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food and Drug Administration Presentation of updated efficacy and safety data from Phase 2b trial and Phase 3 trial design of Descartes-08 in patients with myasthenia gravis expected by year-end Dosing underway in Phase 2 trial of Descartes-08 in patients with systemic lupus erythematosus Dosing underway in first-in-human Phase 1 tr...
Tilray Medical Announces Positive Results from Study on Oral Cannabis ...
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy...
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH...
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that safety and tolerability data from patients treated with Descartes-08 will be featured during a poster presentation at the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 7-10, 2024 in San Diego. A copy of the abstract is available...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.